Latest Estrogen Stories

The effect of acupuncture on postmenopausal symptoms and reproductive hormones: A sham controlled clinical trialTraditional Chinese acupuncture curbs the severity of hot flushes and other menopausal symptoms, suggests a small study published March 7 in Acupuncture in Medicine.The effects did not seem to be related to changes in levels of the hormones responsible for sparking the menopause and its associated symptoms, the study shows.The authors base their findings on 53 middle aged women, all...

New findings published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research, confirm the risk of breast cancer among women who are obese and not physically active, and suggests additional mechanisms beyond estrogen.Scientists from the Women's Health Initiative have found a relationship between obesity, physical activity and triple-negative breast cancer, a subtype of breast cancer characterized by a lack of estrogen, progesterone and...

(Ivanhoe Newswire) "“ Obesity and inactiveness may increase the risk of triple-negative breast cancer, a subtype of breast cancer characterized by lack of estrogen, progesterone, and HER2 expression. Triple-negative breast cancers account for about 10 to 20 percent of all breast cancers and are associated with an extremely poor prognosis because of the lack of targeted drug therapies."Breast cancer is not just one disease. It is a complex combination of many diseases," Amanda...

SEATTLE, Feb. 25, 2011 /PRNewswire/ -- Full-term pregnancy has long been associated with a reduced risk of breast cancer, but a new study finds that the more times a woman gives birth, the higher her risk of "triple-negative" breast cancer, a relatively uncommon but particularly aggressive subtype of the disease. Conversely, women who never give birth have a 40 percent lower risk of such breast cancer, which has a poorer prognosis than other types of breast cancer and doesn't respond to...

High blood levels of a hormone produced in response to stress are linked to post-traumatic stress disorder in women but not men, a study from researchers at Emory University and the University of Vermont has found.The results are scheduled for publication in the Feb. 24 issue of Nature.The hormone, called PACAP (pituitary adenylate cyclase-activating polypeptide), is known to act throughout the body and the brain, modulating central nervous system activity, metabolism, blood pressure, pain...

(Ivanhoe Newswire) "“ Scientists have discovered an unexpected connection between a hormone produced in bone and male fertility.  The study illustrates that the skeletal hormone known as osteocalcin boosts testosterone production to support the survival of the germ cells that go on to become mature sperm.According to Gerard Karsenty of Columbia University, the findings in mice offer the foremost evidence that the skeleton controls reproduction through the production of hormones.Bone was...

Researchers have discovered an unexpected connection between a hormone produced in bone and male fertility.  The study shows that the skeletal hormone known as osteocalcin boosts testosterone production to support the survival of the germ cells that go on to become mature sperm. The researchers said the findings, which were reported in the February 18th issue of Cell, provide the first evidence that the skeleton controls reproduction through the production of hormones. According to Gerard...

A new look at medical literature found no link between heart attacks and the so-called mini-pills contrary to indication reported earlier that women on the popular contraceptive have a higher risk of heart disease, Reuters Health is reporting.Brands such as Micronor and Ovrette, contain the hormone progestin, but not the estrogen of traditional birth control pills. The results also held for other progestin-only birth control implants and shots.Women worldwide take progestin-only...

EMERYVILLE, Calif., Feb. 10, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today articulated for investors the Company's plan of action for 2011 in the development of MF101 (Menerba(TM)). The company also updated its investor information, available on the company's website. "Having positive clinical and non-clinical data to date, regulatory clarity on...

EMERYVILLE, Calif., Feb. 2, 2011 /PRNewswire/ -- Bionovo, Inc. (Nasdaq: BNVI), a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced the closing of its previously announced underwritten public offering of 30,031,200 units at a price per unit of $1.00. Each unit consists of one share of common stock and a warrant to purchase one half of one share of Bionovo common stock at an exercise price of $1.30...